name,category,terms2,4-dienoyl CoA reductase 2, peroxisomal,INTERPRO[450001950$IPR002198:Short-chain dehydrogenase/reductase SDR, 450002088$IPR002347:Glucose/ribitol dehydrogenase, 450014426$IPR016040:NAD(P)-binding domain]
2,4-dienoyl CoA reductase 2, peroxisomal,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790001008$nadp, 790001092$oxidoreductase, 790001128$peroxisome, 790001162$phosphoprotein]
2,4-dienoyl CoA reductase 2, peroxisomal,UP_SEQ_FEATURE[850037909$chain:Peroxisomal 2,4-dienoyl-CoA reductase, 850106258$modified residue, 850106307$nucleotide phosphate-binding region:NADP, 850117578$short sequence motif:Microbody targeting signal, 850118574$splice variant]
4-aminobutyrate aminotransferase,INTERPRO[450004121$IPR004631:4-aminobutyrate aminotransferase, eukaryotic, 450005262$IPR005814:Aminotransferase class-III, 450013864$IPR015421:Pyridoxal phosphate-dependent transferase, major region, subdomain 1]
4-aminobutyrate aminotransferase,KEGG_PATHWAY[470038745$hsa00250:Alanine, aspartate and glutamate metabolism, 470038748$hsa00280:Valine, leucine and isoleucine degradation, 470038758$hsa00410:beta-Alanine metabolism, 470038789$hsa00640:Propanoate metabolism, 470038790$hsa00650:Butanoate metabolism]
4-aminobutyrate aminotransferase,OMIM_DISEASE[520001955$GABA-transaminase deficiency]
4-aminobutyrate aminotransferase,PIR_SUPERFAMILY[630000621$PIRSF000521:4-aminobutyrate transaminase]
4-aminobutyrate aminotransferase,SP_PIR_KEYWORDS[790000012$acetylation, 790000070$Aminotransferase, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000969$mitochondrion, 790001025$neurotransmitter degradation, 790001212$polymorphism, 790001283$pyridoxal phosphate, 790001547$transferase, 790001550$transit peptide]
4-aminobutyrate aminotransferase,UP_SEQ_FEATURE[850001842$chain:4-aminobutyrate aminotransferase, mitochondrial, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118617$transit peptide:Mitochondrion]
AIG2-like domain 1,INTERPRO[450008399$IPR009288:AIG2-like, 450011691$IPR013024:Butirosin biosynthesis, BtrG-like]
AIG2-like domain 1,PIR_SUPERFAMILY[630020204$PIRSF026437:troponin C protein, tina-1 type]
AIG2-like domain 1,SP_PIR_KEYWORDS[790000356$complete proteome]
AIG2-like domain 1,UP_SEQ_FEATURE[850004202$chain:AIG2-like domain-containing protein 1]
ATPase, Ca++ transporting, plasma membrane 4,INTERPRO[450001556$IPR001757:ATPase, P-type, K/Mg/Cd/Cu/Zn/Na/Ca/Na/H-transporter, 450003534$IPR004014:ATPase, P-type cation-transporter, N-terminal, 450005281$IPR005834:Haloacid dehalogenase-like hydrolase, 450005504$IPR006068:ATPase, P-type cation-transporter, C-terminal, 450005830$IPR006408:ATPase, P-type, calcium-transporting, PMCA-type, 450007545$IPR008250:ATPase, P-type, ATPase-associated region, 450016587$IPR018303:ATPase, P-type phosphorylation site]
ATPase, Ca++ transporting, plasma membrane 4,KEGG_PATHWAY[470038829$hsa04020:Calcium signaling pathway]
ATPase, Ca++ transporting, plasma membrane 4,PIR_SUPERFAMILY[630001445$PIRSF001297:Na(+)/K(+)-transporting ATPase alpha chain]
ATPase, Ca++ transporting, plasma membrane 4,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000134$ATP, 790000138$atp-binding, 790000211$calcium, 790000215$calcium transport, 790000218$calmodulin-binding, 790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000743$hydrolase, 790000798$ion transport, 790000899$magnesium, 790000919$membrane, 790000924$membrane protein, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001555$transmembrane, 790001558$transport]
ATPase, Ca++ transporting, plasma membrane 4,UP_SEQ_FEATURE[850000003$active site:4-aspartylphosphate intermediate, 850039441$chain:Plasma membrane calcium-transporting ATPase 4, 850102572$compositionally biased region:Poly-Glu, 850102577$compositionally biased region:Poly-Lys, 850105852$helix, 850106107$metal ion-binding site:Magnesium, 850106258$modified residue, 850111170$region of interest:Calmodulin-binding subdomain A, 850111171$region of interest:Calmodulin-binding subdomain B, 850117294$sequence conflict, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
ATPase, Ca++ transporting, type 2C, member 1,INTERPRO[450000595$IPR000695:ATPase, P-type, H+ transporting proton pump, 450001556$IPR001757:ATPase, P-type, K/Mg/Cd/Cu/Zn/Na/Ca/Na/H-transporter, 450003534$IPR004014:ATPase, P-type cation-transporter, N-terminal, 450005281$IPR005834:Haloacid dehalogenase-like hydrolase, 450005504$IPR006068:ATPase, P-type cation-transporter, C-terminal, 450005835$IPR006413:ATPase, P-type, calcium-transporting, PMR1-type, 450007545$IPR008250:ATPase, P-type, ATPase-associated region, 450016587$IPR018303:ATPase, P-type phosphorylation site]
ATPase, Ca++ transporting, type 2C, member 1,OMIM_DISEASE[520000549$benign chronic pemphigus (Hailey-Hailey disease), 520002207$Hailey-Hailey disease]
ATPase, Ca++ transporting, type 2C, member 1,PIR_SUPERFAMILY[630001445$PIRSF001297:Na(+)/K(+)-transporting ATPase alpha chain]
ATPase, Ca++ transporting, type 2C, member 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000211$calcium, 790000215$calcium transport, 790000356$complete proteome, 790000446$disease mutation, 790000624$golgi apparatus, 790000743$hydrolase, 790000798$ion transport, 790000899$magnesium, 790000919$membrane, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane, 790001558$transport]
ATPase, Ca++ transporting, type 2C, member 1,UP_SEQ_FEATURE[850000003$active site:4-aspartylphosphate intermediate, 850009067$chain:Calcium-transporting ATPase type 2C member 1, 850105918$metal ion-binding site:Calcium 2, 850105922$metal ion-binding site:Calcium 2; via carbonyl oxygen, 850106107$metal ion-binding site:Magnesium, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
ATPase, H+ transporting, lysosomal V0 subunit a1,INTERPRO[450002209$IPR002490:ATPase, V0/A0 complex, 116-kDa subunit]
ATPase, H+ transporting, lysosomal V0 subunit a1,KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation, 470038840$hsa04142:Lysosome, 470038896$hsa05110:Vibrio cholerae infection, 470038897$hsa05120:Epithelial cell signaling in Helicobacter pylori infection]
ATPase, H+ transporting, lysosomal V0 subunit a1,PIR_SUPERFAMILY[630001439$PIRSF001293:V-type ATPase subunit]
ATPase, H+ transporting, lysosomal V0 subunit a1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000739$Hydrogen ion transport, 790000798$ion transport, 790000919$membrane, 790001162$phosphoprotein, 790001555$transmembrane, 790001558$transport]
ATPase, H+ transporting, lysosomal V0 subunit a1,UP_SEQ_FEATURE[850099766$chain:V-type proton ATPase 116 kDa subunit a isoform 1, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
B-cell CLL/lymphoma 7A,INTERPRO[450006210$IPR006804:BCL7, N-terminal]
B-cell CLL/lymphoma 7A,OMIM_DISEASE[520000500$B-cell non-Hodgkin lymphoma, high-grade]
B-cell CLL/lymphoma 7A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
B-cell CLL/lymphoma 7A,UP_SEQ_FEATURE[850007046$chain:B-cell CLL/lymphoma 7 protein family member A, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
B-cell scaffold protein with ankyrin repeats 1,INTERPRO[450016208$IPR017893:DBB domain]
B-cell scaffold protein with ankyrin repeats 1,OMIM_DISEASE[520001949$Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus, 520002051$Genome-wide association study targeting systemic lupus erythematosus., 520004787$Systemic lupus erythmatosus, association with]
B-cell scaffold protein with ankyrin repeats 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000086$ank repeat, 790000153$b-cell activation, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001478$systemic lupus erythematosus]
B-cell scaffold protein with ankyrin repeats 1,UP_SEQ_FEATURE[850007064$chain:B-cell scaffold protein with ankyrin repeats, 850103499$domain:DBB, 850112452$region of interest:Interaction with ITPR2, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
C-type lectin domain family 1, member B,INTERPRO[450001149$IPR001304:C-type lectin, 450014523$IPR016186:C-type lectin-like, 450016659$IPR018378:C-type lectin, conserved site]
C-type lectin domain family 1, member B,SMART[760000026$SM00034:CLECT]
C-type lectin domain family 1, member B,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000848$Lectin, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001409$Signal-anchor, 790001555$transmembrane]
C-type lectin domain family 1, member B,UP_SEQ_FEATURE[850008703$chain:C-type lectin domain family 1 member B, 850102883$disulfide bond, 850103184$domain:C-type lectin, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
CASP8 and FADD-like apoptosis regulator,BBID[10000060$36.Death_of_Key_Intracellular_Targets, 10000108$86.Apoptosis_Nematode&_Vert]
CASP8 and FADD-like apoptosis regulator,BIOCARTA[30000082$h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors , 30000110$h_fasPathway:FAS signaling pathway ( CD95 ), 30000139$h_HivnefPathway:HIV-I Nef: negative effector of Fas and TNF, 30000156$h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation]
CASP8 and FADD-like apoptosis regulator,INTERPRO[450001153$IPR001309:Peptidase C14, ICE, catalytic subunit p20, 450001658$IPR001875:Death effector, 450002131$IPR002398:Peptidase C14, caspase precursor p45, 450010009$IPR011029:DEATH-like, 450010431$IPR011600:Peptidase C14, caspase catalytic, 450014334$IPR015917:Peptidase C14, caspase precursor p45, core]
CASP8 and FADD-like apoptosis regulator,KEGG_PATHWAY[470038843$hsa04210:Apoptosis]
CASP8 and FADD-like apoptosis regulator,PIR_SUPERFAMILY[630029212$PIRSF037643:Casp8 and Fadd-like apoptosis regulator/caspase, types 8/10, 630030829$PIRSF500657:Casp8 and Fadd-like apoptosis regulator]
CASP8 and FADD-like apoptosis regulator,SMART[760000023$SM00031:DED, 760000102$SM00115:CASc]
CASP8 and FADD-like apoptosis regulator,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000733$host-virus interaction, 790001212$polymorphism, 790001304$repeat]
CASP8 and FADD-like apoptosis regulator,UP_SEQ_FEATURE[850009799$chain:CASP8 and FADD-like apoptosis regulator subunit p12, 850009800$chain:CASP8 and FADD-like apoptosis regulator subunit p43, 850103512$domain:DED 1, 850103513$domain:DED 2, 850105852$helix, 850106259$mutagenesis site, 850111188$region of interest:Caspase, 850112147$region of interest:Interaction with caspase-3, 850112149$region of interest:Interaction with caspase-8, 850112150$region of interest:Interaction with caspase-8 propeptide, 850112151$region of interest:Interaction with caspase-8 subunits p18 and p10, 850112316$region of interest:Interaction with FADD, 850112968$region of interest:Interaction with TRAF1 and TRAF2, 850113791$region of interest:Not proteolytically processed and involved in apoptosis inhibition, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
CD2 (cytoplasmic tail) binding protein 2,INTERPRO[450002786$IPR003169:GYF]
CD2 (cytoplasmic tail) binding protein 2,PIR_SUPERFAMILY[630029529$PIRSF037959:CD2 antigen cytoplasmic tail-binding protein 2]
CD2 (cytoplasmic tail) binding protein 2,SMART[760000390$SM00444:GYF]
CD2 (cytoplasmic tail) binding protein 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001212$polymorphism]
CD2 (cytoplasmic tail) binding protein 2,UP_SEQ_FEATURE[850010131$chain:CD2 antigen cytoplasmic tail-binding protein 2, 850104094$domain:GYF, 850105852$helix, 850106258$modified residue, 850117295$sequence variant, 850118575$strand]
CDC42 small effector 1,INTERPRO[450000079$IPR000095:PAK-box/P21-Rho-binding]
CDC42 small effector 1,SMART[760000256$SM00285:PBD]
CDC42 small effector 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000268$cell shape, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000881$lipoprotein, 790000919$membrane, 790001100$palmitate, 790001136$phagocytosis]
CDC42 small effector 1,UP_SEQ_FEATURE[850010188$chain:CDC42 small effector protein 1, 850103411$domain:CRIB, 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850106259$mutagenesis site, 850113403$region of interest:Mediates phosphoinositide-binding, 850118574$splice variant]
D4, zinc and double PHD fingers, family 3,COG_ONTOLOGY[90000118$Transcription / Cell division and chromosome partitioning]
D4, zinc and double PHD fingers, family 3,INTERPRO[450001628$IPR001841:Zinc finger, RING-type, 450001740$IPR001965:Zinc finger, PHD-type, 450006475$IPR007087:Zinc finger, C2H2-type, 450014303$IPR015880:Zinc finger, C2H2-like, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
D4, zinc and double PHD fingers, family 3,SMART[760000158$SM00184:RING, 760000221$SM00249:PHD, 760000323$SM00355:ZnF_C2H2]
D4, zinc and double PHD fingers, family 3,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000311$chromatin regulator, 790000356$complete proteome, 790000937$metal-binding, 790001016$neurogenesis, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
D4, zinc and double PHD fingers, family 3,UP_SEQ_FEATURE[850102006$chain:Zinc finger protein DPF3, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118655$zinc finger region:C2H2-type, 850118878$zinc finger region:PHD-type 1, 850118880$zinc finger region:PHD-type 2]
DNA-damage-inducible transcript 3,BIOCARTA[30000215$h_p38mapkPathway:p38 MAPK Signaling Pathway ]
DNA-damage-inducible transcript 3,INTERPRO[450004309$IPR004827:Basic-leucine zipper (bZIP) transcription factor, 450010528$IPR011700:Basic leucine zipper, 450014991$IPR016670:DNA damage-inducible transcript 3]
DNA-damage-inducible transcript 3,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway]
DNA-damage-inducible transcript 3,OMIM_DISEASE[520003538$Myxoid liposarcoma]
DNA-damage-inducible transcript 3,PIR_SUPERFAMILY[630013356$PIRSF016571:C/EBPzeta_CHOP_DDIT3]
DNA-damage-inducible transcript 3,SMART[760000306$SM00338:BRLZ]
DNA-damage-inducible transcript 3,SP_PIR_KEYWORDS[790000258$cell cycle, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000466$dna-binding, 790000631$growth arrest, 790001065$nucleus, 790001212$polymorphism, 790001271$Proto-oncogene, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
DNA-damage-inducible transcript 3,UP_SEQ_FEATURE[850015529$chain:DNA damage-inducible transcript 3, 850102572$compositionally biased region:Poly-Glu, 850104712$domain:Leucine-zipper, 850117294$sequence conflict, 850117295$sequence variant]
F-box and leucine-rich repeat protein 12,INTERPRO[450001603$IPR001810:Cyclin-like F-box]
F-box and leucine-rich repeat protein 12,SMART[760000228$SM00256:FBOX]
F-box and leucine-rich repeat protein 12,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000853$leucine-rich repeat, 790001304$repeat, 790001593$ubl conjugation pathway]
F-box and leucine-rich repeat protein 12,UP_SEQ_FEATURE[850018786$chain:F-box/LRR-repeat protein 12, 850103725$domain:F-box, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850118574$splice variant]
FKSG83,INTERPRO[450003588$IPR004072:Vomeronasal receptor, type 1]
FOS-like antigen 1,BIOCARTA[30000250$h_ranklPathway:Bone Remodelling]
FOS-like antigen 1,INTERPRO[450000729$IPR000837:Fos transforming protein, 450004309$IPR004827:Basic-leucine zipper (bZIP) transcription factor, 450010446$IPR011616:bZIP transcription factor, bZIP-1]
FOS-like antigen 1,KEGG_PATHWAY[470038846$hsa04310:Wnt signaling pathway]
FOS-like antigen 1,PIR_SUPERFAMILY[630001865$PIRSF001719:fos transforming protein]
FOS-like antigen 1,SMART[760000306$SM00338:BRLZ]
FOS-like antigen 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000449$DNA binding, 790000466$dna-binding, 790001065$nucleus]
FOS-like antigen 1,UP_SEQ_FEATURE[850019993$chain:Fos-related antigen 1, 850102572$compositionally biased region:Poly-Glu, 850102581$compositionally biased region:Poly-Ser, 850102900$DNA-binding region:Basic motif, 850104712$domain:Leucine-zipper]
FOS-like antigen 2,BIOCARTA[30000250$h_ranklPathway:Bone Remodelling]
FOS-like antigen 2,INTERPRO[450000729$IPR000837:Fos transforming protein, 450004309$IPR004827:Basic-leucine zipper (bZIP) transcription factor, 450010446$IPR011616:bZIP transcription factor, bZIP-1]
FOS-like antigen 2,PIR_SUPERFAMILY[630001865$PIRSF001719:fos transforming protein]
FOS-like antigen 2,SMART[760000306$SM00338:BRLZ]
FOS-like antigen 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000449$DNA binding, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein]
FOS-like antigen 2,UP_SEQ_FEATURE[850019994$chain:Fos-related antigen 2, 850102900$DNA-binding region:Basic motif, 850104712$domain:Leucine-zipper, 850106258$modified residue]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),BBID[10000076$56.Macrophage_regulation_of_CD4+T_cells]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),KEGG_PATHWAY[470038868$hsa04650:Natural killer cell mediated cytotoxicity, 470038872$hsa04666:Fc gamma R-mediated phagocytosis, 470038916$hsa05322:Systemic lupus erythematosus]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),OMIM_DISEASE[520002972$Lupus erythematosus, systemic, susceptibility, 520003622$Neutropenia, alloimmune neonatal, 520005034$Viral infections, recurrent]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),PIR_SUPERFAMILY[630002118$PIRSF001980:Fc gamma receptor III]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),SMART[760000357$SM00409:IG]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000761$igg-binding protein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),UP_SEQ_FEATURE[850029060$chain:Low affinity immunoglobulin gamma Fc region receptor III-A, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed,INTERPRO[450000534$IPR000626:Ubiquitin, 450006249$IPR006846:Ribosomal protein S30, 450018184$IPR019954:Ubiquitin conserved site, 450018185$IPR019955:Ubiquitin supergroup, 450018186$IPR019956:Ubiquitin subgroup]
Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed,KEGG_PATHWAY[470038813$hsa03010:Ribosome]
Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed,PIR_SUPERFAMILY[630002173$PIRSF002034:ubiquitin, 630002359$PIRSF002227:ribosomal protein S30e]
Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed,SMART[760000186$SM00213:UBQ]
Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790001212$polymorphism, 790001255$protein biosynthesis, 790001325$ribonucleoprotein, 790001329$ribosomal protein, 790001330$ribosome]
Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed,UP_SEQ_FEATURE[850002053$chain:40S ribosomal protein S30, 850068144$chain:Ubiquitin-like protein FUBI, 850117295$sequence variant]
G protein-coupled receptor 17,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450002032$IPR002286:P2 purinoceptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
G protein-coupled receptor 17,PIR_SUPERFAMILY[630030123$PIRSF038619:uracil nucleotide/cysteinyl leukotriene receptor, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
G protein-coupled receptor 17,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001301$receptor, 790001546$transducer, 790001555$transmembrane]
G protein-coupled receptor 17,UP_SEQ_FEATURE[850099571$chain:Uracil nucleotide/cysteinyl leukotriene receptor, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
G protein-coupled receptor 89C; G protein-coupled receptor 89B; G protein-coupled receptor 89A,INTERPRO[450014108$IPR015672:G-protein coupled receptor 89-related]
G protein-coupled receptor 89C; G protein-coupled receptor 89B; G protein-coupled receptor 89A,PIR_SUPERFAMILY[630011150$PIRSF013287:uncharacterized conserved protein]
G protein-coupled receptor 89C; G protein-coupled receptor 89B; G protein-coupled receptor 89A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001555$transmembrane]
G protein-coupled receptor 89C; G protein-coupled receptor 89B; G protein-coupled receptor 89A,UP_SEQ_FEATURE[850046312$chain:Protein GPR89, 850053876$chain:Putative protein GPR89C, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850118574$splice variant, 850118623$transmembrane region]
G protein-coupled receptor, family C, group 5, member A,INTERPRO[450016286$IPR017978:GPCR, family 3, C-terminal, 450016287$IPR017979:GPCR, family 3, conserved site]
G protein-coupled receptor, family C, group 5, member A,PIR_SUPERFAMILY[630030193$PIRSF038691:retinoic acid-induced G protein-coupled receptors]
G protein-coupled receptor, family C, group 5, member A,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001546$transducer, 790001555$transmembrane]
G protein-coupled receptor, family C, group 5, member A,UP_SEQ_FEATURE[850057425$chain:Retinoic acid-induced protein 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
G-protein signaling modulator 2 (AGS3-like, C. elegans),INTERPRO[450001282$IPR001440:Tetratricopeptide TPR-1, 450002733$IPR003109:GoLoco motif, 450010815$IPR011990:Tetratricopeptide-like helical, 450011693$IPR013026:Tetratricopeptide region, 450017972$IPR019734:Tetratricopeptide repeat]
G-protein signaling modulator 2 (AGS3-like, C. elegans),SMART[760000020$SM00028:TPR, 760000342$SM00390:GoLoco]
G-protein signaling modulator 2 (AGS3-like, C. elegans),SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001304$repeat, 790001537$tpr repeat]
G-protein signaling modulator 2 (AGS3-like, C. elegans),UP_SEQ_FEATURE[850020318$chain:G-protein-signaling modulator 2, 850104071$domain:GoLoco 1, 850104072$domain:GoLoco 2, 850104073$domain:GoLoco 3, 850104074$domain:GoLoco 4, 850106258$modified residue, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117142$repeat:TPR 4, 850117143$repeat:TPR 5, 850117144$repeat:TPR 6, 850117145$repeat:TPR 7, 850117146$repeat:TPR 8, 850117294$sequence conflict]
